POLG1-Related Epilepsy: Review of Diagnostic and Therapeutic Findings

Background: The clinical spectrum associated with POLG1 gene mutations ranges from non-syndromic epilepsy or mild isolated neurological signs to neurodegenerative disorders. Our aim was to review diagnostic findings, therapeutic approaches and outcomes of reported cases of epilepsy related to POLG1 mutation. Methods: The articles for review were identified through a systematic research on PubMed and EMBASE databases from January 2003 to April 2020, searching for the terms “Epilepsy AND POLG OR polymerase gamma,” OR “POLG1”. Results: Forty-eight articles were selected for review, which included 195 patients. Two main peaks of age at epilepsy onset were found: at ages 1 and 13 years. The most frequent seizure type was myoclonic. The occurrence of Status Epilepticus was reported in 46.4% of cases. Epileptiform and slow abnormalities were most frequently seen over occipital regions. Brain Magnetic Resonance Imaging (MRI) revealed increased T2 signal intensities in thalamic regions. Genetic analysis revealed a prevalence of A467T, W748S and G848S (74.2% of patients) mutations. Survival at 5 years was estimated at very low levels (30.2% of patients). Conclusion: In this review, we included cases with both pediatric and adult epilepsy onset. The analysis of data regarding prognosis showed that survival is related to age at onset of epilepsy.

[1]  E. Ruiz-Pesini,et al.  Infectious stress triggers a POLG-related mitochondrial disease , 2019, neurogenetics.

[2]  T. Eichele,et al.  No effect of electrical transcranial direct current stimulation adjunct treatment for epilepsia partialis continua in POLG disease , 2019, Epilepsy & behavior reports.

[3]  T. Nicholson,et al.  Mnesic imbalance: a cognitive theory about autism spectrum disorders , 2008, Annals of General Psychiatry.

[4]  S. Rahman,et al.  POLG-related disorders and their neurological manifestations , 2018, Nature Reviews Neurology.

[5]  X. Shao,et al.  Status epilepticus-related etiology, incidence and mortality: A meta-analysis , 2017, Epilepsy Research.

[6]  Yong-hui Jiang,et al.  Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing , 2017, Scientific Reports.

[7]  Robert W. Taylor,et al.  Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review , 2016, Epilepsia.

[8]  B. Harding,et al.  A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease , 2016, PloS one.

[9]  S. Antonarakis,et al.  Pure Progressive Ataxia and Palatal Tremor (PAPT) Associated with a New Polymerase Gamma (POLG) Mutation , 2016, The Cerebellum.

[10]  I. Nishino,et al.  Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report , 2015, Brain and Development.

[11]  B. Bornstein,et al.  Co-occurrence of four nucleotide changes associated with an adult mitochondrial ataxia phenotype , 2014, BMC Research Notes.

[12]  D. Bartholomew,et al.  Cranial nerve and cervical root enhancement in an infant with polymerase gamma mutation mitochondrial disease. , 2014, Pediatric neurology.

[13]  S. Bijarnia-Mahay,et al.  Mitochondrial DNA depletion syndrome causing liver failure , 2014, Indian Pediatrics.

[14]  Gregory A. Farnum,et al.  Mapping 136 pathogenic mutations into functional modules in human DNA polymerase γ establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes. , 2014, Biochimica et biophysica acta.

[15]  J. Coxhead,et al.  Molecular Pathogenesis of Polymerase Gamma–Related Neurodegeneration , 2014, Annals of neurology.

[16]  M. King,et al.  Explosive onset non-epileptic jerks and profound hypotonia in an infant with Alpers-Huttenlocher syndrome , 2014, Seizure.

[17]  C. Richelme,et al.  Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort , 2013, European Journal of Human Genetics.

[18]  J. Abdenur,et al.  Abnormalities in glycogen metabolism in a patient with alpers' syndrome presenting with hypoglycemia. , 2014, JIMD reports.

[19]  T. Hedderly,et al.  Prospective study of POLG mutations presenting in children with intractable epilepsy: Prevalence and clinical features , 2013, Epilepsia.

[20]  H. Vandebona,et al.  POLG mutations in Australian patients with mitochondrial disease , 2013, Internal medicine journal.

[21]  G. Comi,et al.  POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome , 2013, BMC Neurology.

[22]  B. P. Warrenburg,et al.  POLG mutation presenting with late-onset jerky torticollis , 2013, Journal of Neurology.

[23]  Robert W. Taylor,et al.  What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? , 2012, Brain : a journal of neurology.

[24]  M. Martikainen,et al.  Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet , 2012, Epileptic disorders : international epilepsy journal with videotape.

[25]  E. Holme,et al.  Phenotypic and genotypic variability in Alpers syndrome. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[26]  A. Kirton,et al.  Alpers Syndrome , 2012, Journal of child neurology.

[27]  M. Samuel,et al.  Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[28]  M. King,et al.  Partial status epilepticus - rapid genetic diagnosis of Alpers' disease. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[29]  M. Mackay,et al.  Alpers syndrome with mutations in POLG: clinical and investigative features. , 2011, Pediatric neurology.

[30]  Y. Hellenbroich,et al.  Bowel Obstruction in Patients with Alpers-Huttenlocher Syndrome , 2011, Neuropediatrics.

[31]  A. Zangaladze,et al.  Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype , 2011, Epilepsy & Behavior.

[32]  G. Węgrzyn,et al.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[33]  Robert W. Taylor,et al.  POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts. , 2011, Biochimica et biophysica acta.

[34]  A. Paetau,et al.  POLG1 manifestations in childhood , 2011, Neurology.

[35]  E. Wirrell,et al.  Clinical Reasoning: A 10-month-old boy with myoclonic status epilepticus , 2011, Neurology.

[36]  F. Leijten,et al.  Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations , 2010, Journal of Neurology.

[37]  D. Gilbert,et al.  Rare Autosomal Dominant POLG1 Mutation in a Family With Metabolic Strokes, Posterior Column Spinal Degeneration, and Multi-Endocrine Disease , 2010, Journal of child neurology.

[38]  S. Finnilä,et al.  POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype , 2010, BMC neurology.

[39]  R. Naviaux,et al.  POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders , 2010, Seizure.

[40]  J. Cárdenas,et al.  Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease. , 2010, Seminars in pediatric neurology.

[41]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[42]  I. Harting,et al.  Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features , 2009, Epilepsia.

[43]  E. De Los Reyes,et al.  Phenotypic Variations in 3 Children With POLG1 Mutations , 2009, Journal of child neurology.

[44]  J. Ganesh,et al.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations , 2008, Human mutation.

[45]  T. Klockgether,et al.  Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[46]  K. Majamaa,et al.  Homozygous W748S mutation in the POLG1 gene in patients with juvenile‐onset Alpers syndrome and status epilepticus , 2008, Epilepsia.

[47]  R. Rodenburg,et al.  Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: A cautionary note , 2008, Journal of Inherited Metabolic Disease.

[48]  M. Zeviani,et al.  POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. , 2008, Brain : a journal of neurology.

[49]  V. Ramesh,et al.  Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1) , 2008, Archives of Disease in Childhood.

[50]  S. Dimauro,et al.  Juvenile Alpers disease. , 2008, Archives of neurology.

[51]  S. Dimauro,et al.  Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders , 2007, European Journal of Human Genetics.

[52]  R. Rodenburg,et al.  Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations , 2007, European Journal of Pediatrics.

[53]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[54]  M. Zeviani,et al.  The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.

[55]  Daniel F. Bogenhagen,et al.  Functional Human Mitochondrial DNA Polymerase γ Forms a Heterotrimer* , 2006, Journal of Biological Chemistry.

[56]  R. Naviaux,et al.  POLG mutations in Alpers syndrome , 2005, Neurology.

[57]  D. Turnbull,et al.  Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase γ mutations , 2005, Neurology.

[58]  M. Zeviani,et al.  Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. , 2005, Brain : a journal of neurology.

[59]  C. Broeckhoven,et al.  POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement , 2004, Neurology.

[60]  R. Naviaux,et al.  POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion , 2004, Annals of neurology.

[61]  S. Seneca,et al.  Patient homozygous for a recessive POLG mutation presents with features of MERRF , 2003, Neurology.

[62]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[63]  R. Naviaux,et al.  Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers' syndrome , 1999 .

[64]  R. Naviaux,et al.  Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. , 1999, Annals of neurology.

[65]  William C. Copeland,et al.  Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase γ , 1996 .